BQ Plus Medical Co., Ltd., a professional medical device manufacturer focused on contract manufacturing of IV Administration and Extension Set, announced today that it has received 510(k) clearance for IV Administration Set and Extension Set from the U.S. Food and Drug Administration (FDA).
The market for medical devices in China is predicted to reach $130 billion in 2020, with an annual growth rate of 11 percent from 2020 to 2025. This expansion will continue to be driven by the growing incidence of chronic diseases, rising healthcare expenditures due to income growth
Shanghai will create a “green route” to enable the importation of essential products. Liu Bo, deputy director of Shanghai Customs, said during a regular news conference on May 18 that Shanghai will create a “green route” for the city’s vital businesses, including integrated circuits, biopharmaceuticals, and automobile production.
An intravenous (IV) administration set is a medical device used to administer fluid-based nutrition and drugs directly into the circulation of a patient for rapid results. These devices are used in a variety of therapeutic settings, including hospitals, nursing homes, and private residences
